The North america dna synthesis market size surpassed USD 1.69 billion in 2025 and is predicted to reach around USD 7.58 billion by 2035, registering a CAGR of 16.2% from 2026 to 2035.Growing due to strong biotechnology funding, advanced genomics research, and the presence of major players accelerating innovation.

North America DNA Synthesis Market Statical Scope

Synthetic biology is being widely used in drug development and discovery. Accuracy and speed are increasing with the use of AI-driven DNA design platforms. Applications for gene synthesis are growing due to increased demand for personalized medicine. Innovation and commercialization are being accelerated by strategic partnerships between biotech companies

North America DNA Synthesis Market, By Service Type, 2025 (%)

• Oligonucleotide Synthesis- Oligonucleotide synthesis leads the market with a market share of 68.00% driven by rising demand for PCR sequencing and synthetic biology applications.
• Gene Synthesis- Gene synthesis accounts for a significant portion with a market share of 32.00% driven by increasing adoption in gene editing, vaccine development, and personalized medicine.

North America DNA Synthesis Market, By Application, 2025 (%)

• Research and Development- Research and development leads the market, with 45% driven by expanding genomics research and drug discovery investments.
• Diagnostics- Diagnostics account for a significant portion, representing a share of 27% driven by growing use of molecular diagnostics and precision testing technologies.
• Therapeutics- Therapeutics represent a notable segment capturing a share of 28% driven by increasing development of gene- and cell-based therapies.

North America DNA Synthesis Market, By End Use, 2025 (%)

• Biopharmaceutical & Diagnostics Companies- Biopharmaceutical & diagnostic companies lead the market with a market share of 42% driven by strong pipeline expansion and commercialization of advanced therapies.
• Academic & Research Institutes- Academic & research institutes account for a significant portion, representing a share of 38% driven by increased funding for life science research and innovation.
• Contract Research Organizations- Contract research organizations hold a notable segment, capturing a share of 20% driven by rising outsourcing of complex synthesis and research activities.

Top Companies in the North America Compound Management Market

• Thermo Fisher Scientific, Inc
• Twist Bioscience
• BIONEER CORPORATION
• Eton Bioscience, Inc.
• LGC Biosearch Technologies
• IBA Lifesciences GmbH
• Eurofins Scientific
• Integrated DNA Technologies, Inc.
• Quintara Biosciences
• GenScript

Segments Covered in the Report

By Service Type

• Oligonucleotide Synthesis
• Gene Synthesis

By Application

• Research & Development
• Diagnostics
• Therapeutics

By End Use

• Biopharmaceutical & Diagnostics Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)